Metadata

Name CCU002_02 Cardiomyopathy
Type Disease or Syndrome
Group Disease or Syndrome
Data Sources




Clinical Terminologies SNOMED-CT
ICD-10
Codelists covid_impact_ccu00202_cardiomyopathy_England_ICD10.csv covid_impact_ccu00202_cardiomyopathy_England_SNOMEDCT.csv
Valid Event Data Range 08/12/2020 - 18/03/2021
Sex Female
Male
Authors CVD-COVID-UK consortium, William N Whiteley, Samantha Ip, Jennifer A Cooper, Thomas Bolton, Spencer Keene, Venexia Walker, Rachel Denholm, Ashley Akbari, Efosa Omigie, Sam Hollings, Emanuele Di Angelantonio, Spiros Denaxas, Angela Wood, Jonathan A C Sterne, Cathie Sudlow
Agreement Date 23 Aug 2021
Version (UUID) Revision 1 (COVID-IMPACT)

Phenotypes

Code type is set to 1 for incident events, and 0 for prevalent events.

England hospitalization EHR: Cardiomyopathy diagnosis

terminology code term code_type
ICD10 I42.0 Dilated cardiomyopathy 1.0
ICD10 I42.6 Alcoholic cardiomyopathy 1.0
ICD10 I25.5 Ischaemic cardiomyopathy 1.0
ICD10 I42.3 Endomyocardial (eosinophilic) disease 1.0
ICD10 I42.5 Other restrictive cardiomyopathy 1.0
ICD10 I42.7 Cardiomyopathy due to drugs and other external agents 1.0
ICD10 I42.8 Other cardiomyopathies 1.0
ICD10 I42.9 Cardiomyopathy, unspecified 1.0
ICD10 I43 Cardiomyopathy in diseases classified elsewhere 1.0

England primary care EHR: Cardiomyopathy diagnosis

terminology code term code_type
SNOMEDCT 1321241000000105 Cardiomyopathy caused by severe acute respiratory syndrome coronavirus 2 (disorder) 1.0
SNOMEDCT 240077004 Severe scapuloperoneal muscular dystrophy with cardiomyopathy (disorder) 1.0
SNOMEDCT 240072005 Benign scapuloperoneal muscular dystrophy with cardiomyopathy (disorder) 1.0

Publication

Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, and thrombocytopenic events: whole population cohort study in 46 million adults in England

CVD-COVID-UK consortium, William N Whiteley, Samantha Ip, Jennifer A Cooper, Thomas Bolton, Spencer Keene, Venexia Walker, Rachel Denholm, Ashley Akbari, Efosa Omigie, Sam Hollings, Emanuele Di Angelantonio, Spiros Denaxas, Angela Wood, Jonathan A C Sterne, Cathie Sudlow

medRxiv 2021.08.18.21262222; doi: https://doi.org/10.1101/2021.08.18.21262222